Skip to main content

Published locations for SABCS: CREATE-X – Capecitabine is efficacious against residual HER2-negative breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. SABCS: CREATE-X – Capecitabine is efficacious against residual HER2-negative breast cancer

User login

  • Reset your password
  • /content/sabcs-create-x-capecitabine-efficacious-against-residual-her2-negative-breast-cancer
  • /oncologypractice/article/105067/breast-cancer/sabcs-create-x-capecitabine-efficacious-against
  • /hematology-oncology/article/105067/breast-cancer/sabcs-create-x-capecitabine-efficacious-against
  • /breast-cancer-icymi/article/105067/breast-cancer/sabcs-create-x-capecitabine-efficacious-against